Nan Bing;Linda Perry Briley;Charles J. Cox;Colin F. Spraggs;Laura R. Budde
发明人:
Nan Bing,Linda Perry Briley,Laura R. Budde,Charles J. Cox,Colin F. Spraggs
申请号：
US13391579
公开号：
US20120156200A1
申请日:
2010.08.20
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Methods are provided of treating a human for cancer comprising administering at least one dose of lapatinib, or a pharmaceutically acceptable salt or composition thereof, to a patient, wherein said patient does not have one or more allelic polymorphisms selected from the group of: HLA-DQA1*0201, HLA-DQB1*0202, and HLA-DRB1*0701. Patients may also be free of genotypes in TNXB； rs12153855 and/or rs17207923.
